22880010|t|Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block.
22880010|a|Since ancient times ursodeoxycholic acid (UDCA), a constituent of bile, is used against gallstone formation and cholestasis. A neuroprotective action of UDCA was demonstrated recently in models of Alzheimer's disease and retinal degeneration. The mechanisms of UDCA action in the nervous system are poorly understood. We show now that UDCA promotes wakefulness during the active period of the day, lacking this activity in histamine-deficient mice. In cultured hypothalamic neurons UDCA did not affect firing rate but synchronized the firing, an effect abolished by the GABA(A)R antagonist gabazine. In histaminergic neurons recorded in slices UDCA reduced amplitude and duration of spontaneous and evoked IPSCs. In acutely isolated histaminergic neurons UDCA inhibited GABA-evoked currents and sIPSCs starting at 10 microM (IC(50) = 70 microM) and did not affect NMDA- and AMPA-receptor mediated currents at 100 microM. Recombinant GABA(A) receptors composed of alpha1, beta1-3 and gamma2L subunits expressed in HEK293 cells displayed a sensitivity to UDCA similar to that of native GABA(A) receptors. The mutation alpha1V256S, known to reduce the inhibitory action of pregnenolone sulphate, reduced the potency of UDCA. The mutation alpha1Q241L, which abolishes GABA(A)R potentiation by several neurosteroids, had no effect on GABA(A)R inhibition by UDCA. In conclusion, UDCA enhances alertness through disinhibition, at least partially of the histaminergic system via GABA(A) receptors.
22880010	17	37	ursodeoxycholic acid	Chemical	MESH:D014580
22880010	39	43	UDCA	Chemical	MESH:D014580
22880010	54	63	histamine	Chemical	MESH:D006632
22880010	110	130	ursodeoxycholic acid	Chemical	MESH:D014580
22880010	132	136	UDCA	Chemical	MESH:D014580
22880010	178	197	gallstone formation	Disease	MESH:D042882
22880010	202	213	cholestasis	Disease	MESH:D002779
22880010	243	247	UDCA	Chemical	MESH:D014580
22880010	287	306	Alzheimer's disease	Disease	MESH:D000544
22880010	311	331	retinal degeneration	Disease	MESH:D012162
22880010	351	355	UDCA	Chemical	MESH:D014580
22880010	425	429	UDCA	Chemical	MESH:D014580
22880010	533	537	mice	Species	10090
22880010	572	576	UDCA	Chemical	MESH:D014580
22880010	660	668	GABA(A)R	Gene	14406
22880010	680	688	gabazine	Chemical	MESH:C049853
22880010	734	738	UDCA	Chemical	MESH:D014580
22880010	845	849	UDCA	Chemical	MESH:D014580
22880010	860	864	GABA	Chemical	MESH:D005680
22880010	1053	1068	alpha1, beta1-3	Gene	597;4698;28905;28907;28908
22880010	1103	1109	HEK293	CellLine	CVCL:0045
22880010	1143	1147	UDCA	Chemical	MESH:D014580
22880010	1260	1281	pregnenolone sulphate	Chemical	MESH:C018370
22880010	1306	1310	UDCA	Chemical	MESH:D014580
22880010	1331	1336	Q241L	ProteinMutation	tmVar:p|SUB|Q|241|L;HGVS:p.Q241L;VariantGroup:0;OriginalGene:14406;CorrespondingGene:2566;CorrespondingSpecies:10090
22880010	1354	1362	GABA(A)R	Gene	14406
22880010	1419	1427	GABA(A)R	Gene	14406
22880010	1442	1446	UDCA	Chemical	MESH:D014580
22880010	1463	1467	UDCA	Chemical	MESH:D014580
22880010	Association	MESH:D014580	28907
22880010	Negative_Correlation	MESH:D014580	MESH:D012162
22880010	Negative_Correlation	MESH:D014580	MESH:D042882
22880010	Negative_Correlation	MESH:D014580	14406
22880010	Association	MESH:D014580	28905
22880010	Negative_Correlation	MESH:D014580	MESH:D000544
22880010	Association	MESH:D014580	28908
22880010	Association	MESH:D014580	597
22880010	Negative_Correlation	MESH:D014580	MESH:D002779
22880010	Negative_Correlation	MESH:C049853	14406
22880010	Association	MESH:D014580	4698
22880010	Negative_Correlation	MESH:D005680	MESH:D014580
22880010	Association	MESH:D006632	MESH:D014580

